Mechanisms of interference with the MHC class I-restricted pathway of antigen presentation by herpesviruses

Immunology and Cell Biology

Volumn 74, Issue 6, 1996, Pages 523-526

  Hill, Ann B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

antigen presentation; cytomegalovirus; cytotoxic T lymphocyte; Epstein Barr virus; herpes simplexvirus; herpesvirus; latency; MHC class I; natural killer cell; transporter associated with antigen processing

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; REVIEW;

CYTOMEGALOVIRUS; DNA VIRUSES; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; MOUSE CYTOMEGALOVIRUS 1; MURINAE; SIMPLEXVIRUS;

EID: 0029729042     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.85     Document Type: Review

References (27)

1. McGeoch DJ, Cook S, Dolan A, Jamieson FE, Telford EA. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Molec. Biol. 1995; 247: 443-58.
2. Roizman B. Herpesviridae: A brief introduction. In: Fields BN, Knippe DM (eds) Virology, Vol. 2. New York: Raven Press Ltd 1990; 1787-94.
3. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 1989; 7: 601-24.
4. Heemels M-T, Ploegh HL. Generation, translocation and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 1995; 64: 463-91.
5. Williams DB, Vassilakos A, Sun W-K. Peptide presentation by MHC class I molecules. Trends Cell Biol. 1996; 6: 267-73.
6. Yokomaya WM. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc. Natl Acad. Sci. USA 1995; 92: 3081-5.
7. Levitskaya J, Coram M, Levitsky V et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995; 375: 685-8.
8. + T lymphocytes. Cell 1994; 77: 525-35.
9. Hill AB, Jugovic P, York I et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995; 375: 411-15.
10. Hill AB, Lee SP, Haurum JS et al. Class I MHC-restricted cytotoxic t lymphocytes specific for EBV nuclear antigens fail to lyse the EBV-transformed B-lymphoblastoid cell lines against which they were raised. J. Exp. Med. 1995; 181: 2221-18.
11. Tomazin R, Hill AB, Jugovic P et al. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 1996; 15: 3256-66.
12. Beersma MFC, Bijlmakers MJE, Ploegh H. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I heavy chains. J. Immunol. 1993; 151: 4455-64.
13. Warren AP, Ducroq DH, Lehner PJ, Borysiewicz LK. Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J. Virol. 1994; 68: 2822-9.
14. Yamashita Y, Shimokata S, Saga S, Mizuno S, Tsurumi T, Nishiyama Y. Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells. J. Virol. 1994; 68: 7933-43.
15. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 1995; 69: 4830-41.
16. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996; 84: 769-79.
17. Ahn K, Angulo A, Ghazal P, Yang Y, Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl Acad. Sci. USA 1996; 93: 10990-5.
18. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988; 331: 269-72.
19. Browne H, Smith G, Beck S, Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 1990; 347: 770-2.
20. Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, Bjorkman PJ. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 1995; 3: 583-90.
21. del Val M, Volkmer H, Rothbard JB et al. Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J. Virol. 1988; 62: 3965-72.
22. Campbell AE, Slater JS, Cavanaugh VJ, Stenberg RM. An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes. J. Virol 1992; 66: 3011-17.
23. del Val M, Hengel H, Hacker H et al. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 1992; 176: 729-38.
24. Thale R, Lucin P, Schneider K, Eggers M, Koszinowski UH. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 1994; 68: 7757-65.
25. Reddehase MJ, Fibi MR. Keil GM, Koszinowski UH. Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J. Virol. 1986; 60: 1125-9.
26. Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 1996 (in press).
27. Davis-Poynter NJ, Farrell HE. Masters of deception: A review of herpesvirus immune evasion strategies. Immunol. Cell Biol. 1996; 74: 513-21.